Biotech Values

[p3analyze]

Point taken my critique was clearly off target in terms of censoring as you pointed out patients had to have PD'd to cross over. However analyzing a crossed over patient pretending it was the same as a de novo randomized patients violate the principle of randomization due to selection bias. I highly doubt that was in the apriori sap. Cheers!